A rare, human prostate oncocyte cell originates from the prostatic carcinoma (DU145) cell line

Ultrastructural Pathology

Volumn 37, Issue 6, 2013, Pages 440-448

  Gilloteaux, Jacques ^a   Eze, Nkechinyere ^a   Jamison, James M ^b   McGuire, Karen ^b   Summers, Jack L ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Summa Research Foundation   (United States)

Author keywords

Carcinoma; DU145; Mitochondria; Oncocyte; Prostate

Indexed keywords

GLYCOGEN; RIBONUCLEOPROTEIN;

ADENOCARCINOMA; ARTICLE; BRAIN TUMOR; CELL SIZE; CHEMISTRY; HUMAN; MALE; METASTASIS; MITOCHONDRION; NUCLEAR SHAPE; PROSTATE TUMOR; THYROID PARAFOLLICULAR CELL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOCARCINOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS SHAPE; CELL SIZE; GLYCOGEN; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; OXYPHIL CELLS; PROSTATIC NEOPLASMS; RIBONUCLEOPROTEINS;

EID: 84887860332     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2013.814739     Document Type: Article

References (75)

1. Hamperl H. 1933. Beitrage z8r normalen und pathologischen Histologie menschlicher Speicheldr8sen. Z Mikrosk-Anat Forsch 1931;27: 1-55.
2. Christie AC.Ahistochemical property of the oxyphil cells of the human parathyroid glands. J Clin Pathol 1955;8: 302-9.
3. Munger BL, Roth SI. The cytology of the normal parathyroid glands of man and Virginia deer: a light and electron microscopic study with morphologic evidence of secretory activity. J Cell Biol 1963;16: 379-400.
4. Trier JS. The fine structure of the parathyroid gland. J Biophys Biochem Cytol 1958;4:13-22.
5. Schulz H. Electron microscopy of oncocytomas and carcinoid tumors. In: Grundmann E, ed. Special topics in Carcinogenesis-recent results in cancer research. Berlin: Springer Verlag, 1974:63-8.
6. Christie AC. The parathyroid oxyphil cells. J Clin Pathol 1967;20: 591-602.
7. Hamperl, H. Onkocyten und Onkocytom. Virchows Arch Path Anat 1962;335: 452-83.
8. Eneroth CM. Oncocytoma of major salivary glands. J Laryngol Otol 1965;79: 1064-72.
9. Baloch ZW, LiVolsi VA. Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol 1999;16: 190-9.
10. Guaraldi F, Zang G, Dackiw AP, Caturegli P. Oncocytic mania: a review of gland. Lab Invest 1970;23: 567-80.
11. Tandler B, Hutter RVP, Erlandson RA. Ultrastructure of oncocytoma of the parotid gland. Lab Invest 1970;23: 567-80.
12. Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland: a series of 22 cases and a review of literature. Cancer 1996;78: 2281-7.
13. Hürthle K. Beitrage zur Kenntiss der Sekretionsvorgangs in der Schilddrüse. Arch Gesamte Physiol 1894;56: 1-44.
14. Satoh M, Yagawa K. Electron microscopic study on mitochondria in Hürthle cell adenoma of thyroid. Acta Pathol Jpn 1981;31: 1079-87.
15. Nesland JM, Sobrinho-Simoes MA, Holm R, et al. Hürthlecell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 1985;8: 269-90.
16. Montone KT, Baloch ZW, LiVolsi VA. The thyroid H8rthle (oncotic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 2008;132: 1241-50.
17. Zerban H, Nogueira E, Riedasch G, Bannash P. Renal oncocytoma: origin from the collecting duct. Virchows Arch B 1987;52: 375-87.
18. Störkel S. Carcinoma and oncocytoma of the kidney: phenotypic characteristics and prognostic features. Veroff Pathol 1993;140: 1-65.
19. Neuzillet Y, Lechevalier E, Andre M, et al. Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology 2005;66: 1181-5.
20. Kovacs K, Horvath E, Bilbao JM. Oncocytes in the anterior lobe of the human pituitary gland. Acta Neuropathol 1974; 27: 43-53.
21. Shah RK, Oto A, Ozkan OS, et al. Adrenal oncocytoma: US and CT findings. JBR-BTR 2004;87: 180-2.
22. Geyer FC, de Biase D, Lambros MB, et al. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology. Breast Cancer Res Treat 2012;132: 15-28.
23. Coburn V, Radfar A, Snook D, Mahalingham M. Cutaneous oncocytoma-a report of three cases and review of the literature. J Cutan Pathol 2007;34: 355-9.
24. Ordóntild;ez NG, Ro JY, Ayala AG. Metastatic prostatic carcinoma presenting as an oncocytic tumor. Am J Surg Pathol 1992;16: 1007-12.
25. Fiandrino G, Lucioni M, Filippin F, et al. Prostatic adenocarcinoma with oncocytic features. J Clin Pathol 2011;64: 177-8.
26. Khadim MT, Hassan U, Ejaz A, Mamoon N. Oncotic variant of prostatic adenocarcinoma-a case report. Pakistan Armed Forces Med J 2012;2: www.pafmj.org/ showdetails.php?id=224&t=c
27. Gilloteaux J, Jamison JM, Venugopal M, et al. Scanning electron microscopy and transmission electron microscopy aspects of synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Scanning Microsc Intl 1995;9: 159-73.
28. Jamison JM, Gilloteaux J, Venugopal M, et al. Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell 1996; 28: 687-701.
29. Taper HS, Jamison JM, Gilloteaux J, et al. In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C: K3. J Histochem Cytochem 2001;49: 109-19.
30. Gilloteaux J, Jamison JM, Arnold D, Summers JL. Synergistic, antitumor cytotoxic actions of ascorbate and menadione on human prostate carcinoma (DU145) cells: organelles' injuries preceding cell death by autoschizis. Anat Rec A, in press.
31. Gilloteaux J, Jamison JM, Neal DR, Summers JL. Xenotransplanted human prostate carcinoma (DU145) cells develop into carcinomas and cribriform carcinomas: ultrastructural aspects. Ultrastruct Pathol 2012;36: 294-311.
32. Gilloteaux J, Jamison JM, Arnold D, Summers JL. Human prostate DU145 carcinoma cells implanted in nude mice remove the peritoneal mesothelium to invade and grow as carcinomas. Anat Rec A 2013;296: 40-55.
33. Mickey DD, Stone KR, Wunderli H, et al. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1977;37: 4049-58.
34. Mickey DD, Stone KR, Wunderli H, et al. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Prog Clin Biol Res 1980;37:67-84.
35. Stone KR, Mickey DD, Wunderli H, et al. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978;21: 274-81.
36. Chakraborty J, Von Stein GA. Pleiomorphism of human prostatic cancer cells (DU145) in culture-the role of the cytoskeleton. Exp Mol Pathol 1986;44: 235-49.
37. Alimirah F, Chen J, Basrawala Z, et al. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett 2006;80: 2294-300.
38. Frost JK. In: Wied JI, ed. The cell in health and Disease: an evaluation of cellular morphologic expression of biologic behaviour, 2nd ed, rev. Basel: Karger/Monogr Clin Cytol. 1986;2: 1-304.
39. Srigley JR, Hartwick WL. Selected ultrastructural aspects of urothelial and prostatic tumors. Ultrastruct Pathol 1988; 12: 49-65.
40. Carruba G, Pavone C, Pavone-Macalusa M, et al. Morphometry of in vitro systems: an image analysis of two human prostate cancer cell lines (PC-3 and DU145). Pathol Res Pract 1989;185: 704-8.
41. Mao P, Nakao K, Angrist A. Human prostatic carcinoma: an electron microscope study. Cancer Res 1966;26: 955-73.
42. Bernardino J, Bourgeois CA, Muleris M, et al. Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization. Cancer Genet Cytogenet 1997;96: 123-8.
43. Celesk RA, Pollard M. Ultrastructural cytology of prostate carcinoma cells from Wistar rats. Invest Urol 1976;14: 95-9.
44. Brehmer B, Riemann JF, Bloodworth Jr JM, Madsen PO. Electron microscopic appearance of cells from carcinoma of the prostate in monolayer tissue culture. Urol Res 1973;1: 27-31.
45. Jerónimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20: 5195-8.
46. Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med 2007;7: 121-31.
47. Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 2010;1805: 141-52.
48. Petros JA, Baumann AK, Ruiz-Pesini E, et al. MtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102: 719-24.
49. Ritter CS, Haughey BH, Miller B, Brown AJ. Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 2012;97: E1499-505.
50. Kulawiec M, Arnouk H, Desouki MM, et al. Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biol Ther 2006;5: 967-75.
51. Kim HK, Park WS, Kang SH, et al. Mitochondrial alterations in human gastric carcinoma cell line. Am J Physiol Cell Physiol 2007;293: C761-71.
52. Ma W, Sung HJ, Park JY, et al. A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr 2007;39:243-6.
53. Dakubo GD, Parr RL, Costello LC, et al. Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol 2006;59: 10-16.
54. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927;8: 519-30.
55. Pedersen PL. Tumor mitochondria and the bioenergetics of cancer cells. J Progr Expl Tumor Resh 1978;22: 198-274.
56. Chowdhury SKR, Gemin A, Singh G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun 2005;333: 1139-45.
57. Tallini G. Oncocytic tumours. Virchows Arch 1998;433: 5-12.
58. Tallini G, Hsueh A, Liu S, et al. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization. Lab Invest 1999;79: 547-55.
59. Máximo V, Soares P, Lima J, et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol 2002;160: 1857-65.
60. Sobrinho-Simões M, Máximo V, Castro IV, et al. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 2005;13: 29-35.
61. Gasparre G, Bonora E, Tallini G, Romeo G. Molecular features of thyroid oncocytic tumors. Mol Cell Endocrinol 2010;321: 67-76.
62. Carew JS, Huang P. Mitochondrial defects in cancer. BioMed Central 2002;1:9: 1-12.
63. Shapovalov Y, Hoffman D, Zuch D, et al. Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication. J Biol Chem 2011;286: 22331-8.
64. Higgins LH, Withers HG, Garbens A, et al. Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta 2009;1787: 1433-43.
65. Pang B, Zhang H, Wang J, et al. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression. Prostate 2009;69: 1176-87.
66. Schnier JB, Nishi K, Gumerlock PH, et al. Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer. BMC Urol 2005;24;5:6.
67. Pereira L, Soares P, Máximo V, Samuels DC. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncotic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors. BMC Cancer 2012; 12: 53;doi:10.1186/1471- 2407-12-53.
68. Collins TJ, Berridge MJ, Lipp P, Bootman MD. Mitochondria are morphologically and functionally heterogeneous within cells. EMBO J 2002;21: 1616-27.
69. Dong J-T. Prevalent mutations in prostate cancer. J Cell Biochem 2006;97: 433-47.
70. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24: 68-72.
71. Sonveaux P, Vegran P, Schroeder T, et al. Targeting lactatefuelled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008;118: 3930-42.
72. Bannash P. The cytoplasm of hepatocytes during carcinogenesis. In: Rentchnick P, ed. Recent results in cancer research. New York: Springer Verlag, 1968.
73. Rousset M, Zweibaum A, Fogh J. Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins. Cancer Res 1981;41: 1165-70.
74. Brandt F, Carlson L-A, Hartl FU, et al. The threedimensional organization of polyribosomes in intact human cells. Mol Cell 2010;39: 560-9.
75. Di Palma S, Lambros MB, Savage K, et al. Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells. J Clin Pathol 2007;60: 492-9.